ASSET PURCHASE AGREEMENTAsset Purchase Agreement • January 6th, 2023 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Delaware
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 5, 2023 (the “Effective Date”), by and between bluebird bio, Inc., a corporation organized under the laws of Delaware (“Seller”), and Bristol-Myers Squibb Company, a corporation incorporated under the laws of Delaware (“Buyer”). Buyer and Seller may hereinafter be referred to individually as a “Party” and collectively as the “Parties”.
